Alendronate News
More Osteoporosis Patients Stay On Treatment With Effective Once-Monthly
New data from a 6 month clinical trial shows that women with postmenopausal osteoporosis have a 47% improvement in persistence with the once-monthly Bonviva treatment programme compared with weekly alendronate.
Osteoporosis drug may also normalize heart rate
Treatment with raloxifene appears to reduce heart rate variability in elderly women with osteoporosis, Turkish researchers report in the American Journal of Obstetrics and Gynecology.
Leblanc and his colleagues are studying the effects of the drug alendronate.
Leblanc and his colleagues are studying the effects of the drug alendronate (fossamax, merck & co.) On men who are undergoing long periods of bed rest.LeBlanc emphasizes the importance of resistive exercises, such as...
Alendronate beats risedronate in increasing BMD
Postmenopausal women with low bone density who received once-weekly alendronate 70 mg had significantly greater increases in bone mineral density and reductions in markers of bone turnover over a 2-yearperiod, compared with those...
Alendronate prevents bone loss in men on androgen deprivation therapy
Once weekly oral alendronate (Fosamax), used to treat osteoporosis in postmenopausal women, also helps prevent bone loss associated with hormonal treatment of prostate cancer, according to a study.